ESC 365 - What are the implications of GLOBAL LEADERS for clinical practice?

ACVC Premium Access

What are the implications of GLOBAL LEADERS for clinical practice?

Session: The trial of the trial: Assessing GLOBAL LEADERS innovations, limitations and implications for clinical practice

Topic: Other

Speaker: Professor K. Huber (Vienna, AT)

Event: Acute Cardiovascular Care 2019

Congress Presentation

Add to my library

About the speaker

Professor Kurt Huber

Sigmund Freud University Vienna, Vienna (Austria)

54 presentations

10 followers

4 more presentations in this session

The trial of the trial: Assessing GLOBAL LEADERS innovations, limitations and implications for clinical practice - Introduction.

Speaker: Professor P. Vranckx (Hasselt, BE)

Design, statistics, and pitfalls of a pragmatic clinical trial.

Speaker: Professor K. Rowan (London, GB)

Compliment the Investigators Assessment: the GLOBAL LEADERS Adjudication SubSTudy.

Speaker: Associate Professor A. Franzone (Naples, IT)

The trial of the trial: Assessing GLOBAL LEADERS innovations, limitations and implications for clinical practice - Conclusion.

Speaker: Professor M. Valgimigli (Lugano, CH)

Access the full session

The trial of the trial: Assessing GLOBAL LEADERS innovations, limitations and implications for clinical practice

Speakers: Professor K. Huber, Professor P. Vranckx, Professor K. Rowan, Associate Professor A. Franzone, Professor M. Valgimigli

About the event

Acute Cardiovascular Care 2019

2 March - 4 March 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources